SLFN11 Enhances PARPi Sensitivity in Ovarian Cancer via Ubiquitin-Mediated Stabilization
{{output}}
Schlafen family member 11 (SLFN11), implicated in cancer drug resistance, may improve poly(ADP-ribose) polymerase inhibitor (PARPi) efficacy. This study investigates SLFN11's role in epithelial ovarian cancer (EOC) progression and its influence on PARPi sensi... ...
